5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.58▼ | 1.60▼ | 1.59▼ | 1.53▲ | 1.39▲ |
MA10 | 1.60▼ | 1.60▼ | 1.55▲ | 1.48▲ | 1.56▲ |
MA20 | 1.60▼ | 1.53▲ | 1.52▲ | 1.38▲ | 2.91▼ |
MA50 | 1.52▲ | 1.54▲ | 1.52▲ | 1.61▼ | 6.02▼ |
MA100 | 1.55▲ | 1.45▲ | 1.38▲ | 3.08▼ | 8.47▼ |
MA200 | 1.52▲ | 1.36▲ | 1.50▲ | 5.82▼ | 14.29▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.009▼ | 0.007▲ | 0.010▲ | 0.056▲ | 0.053▲ |
RSI | 50.554▲ | 55.225▲ | 55.895▲ | 51.454▲ | 30.717▼ |
STOCH | 22.829 | 64.222 | 81.512▲ | 68.814 | 18.720▼ |
WILL %R | -68.750 | -37.500 | -21.429▲ | -25.926 | -88.325▼ |
CCI | -75.345 | 9.972 | 60.950 | 70.477 | -52.299 |
Thursday, May 01, 2025 06:00 AM
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has named Hui Liu as Director of Biostatistics to bolster its efforts as the company progresses with its pivotal Phase 3 Alzheimer’s ...
|
Wednesday, April 30, 2025 05:19 AM
Q1 2025 Earnings Call Transcript April 29, 2025 Novartis AG beats earnings expectations. Reported EPS is $2.28, expectations were $2.12. Operator: Good morning and good afternoon, and welcome to the ...
|
Wednesday, April 30, 2025 12:05 AM
Novartis AG (NVS) reports robust sales and income growth, while navigating challenges and enhancing its product pipeline.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 1.46 | 1.65 | 1.45 | 1.57 | 333,400 |
30/04/25 | 1.45 | 1.52 | 1.36 | 1.49 | 216,600 |
29/04/25 | 1.57 | 1.57 | 1.455 | 1.47 | 183,389 |
28/04/25 | 1.60 | 1.60 | 1.53 | 1.55 | 125,200 |
25/04/25 | 1.63 | 1.64 | 1.49 | 1.57 | 265,877 |
24/04/25 | 1.54 | 1.68 | 1.50 | 1.64 | 464,000 |
23/04/25 | 1.62 | 1.62 | 1.49 | 1.51 | 538,737 |
22/04/25 | 1.40 | 1.59 | 1.40 | 1.47 | 1,011,800 |
21/04/25 | 1.21 | 1.71 | 1.21 | 1.35 | 3,483,000 |
17/04/25 | 1.24 | 1.27 | 1.19 | 1.22 | 73,587 |
|
|
||||
|
|
||||
|
|